ArticleAnnals of medicine and surgery (2012)2025
Successful radical nephrectomy for renal cell carcinoma in a pregnant patient: a case report and literature review.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Renal cell carcinoma (RCC) in pregnancy is extremely rare, with an estimated incidence of 13 per million pregnancies. Papillary RCC, a less common subtype, poses unique diagnostic and therapeutic challenges during gestation. Case presentation: A 38-year-old woman at 26 weeks' gestation presented with persistent right flank pain unresponsive to initial treatment. Imaging via ultrasound and magnetic resonance imaging (MRI) revealed a large right renal mass. Following multidisciplinary evaluation, an open radical nephrectomy was performed. Histopathology confirmed papillary RCC, pT2, Grade III. Both maternal and fetal outcomes were favorable, with no recurrence at 7 months' follow-up. Clinical discussion: Diagnosing RCC during pregnancy is challenging due to symptom overlap with common gestational disorders such as urinary tract infections or preeclampsia. Ultrasound and MRI, which avoid ionizing radiation, are the preferred imaging modalities, but can be limited by anatomical changes during pregnancy. Surgical resection remains the definitive treatment, with the second trimester offering a balance between minimizing fetal risk and preventing tumor progression. Decisions on timing and surgical approach must be individualized, considering tumor size, location, and gestational age. A multidisciplinary team involving urology, obstetrics, anesthesiology, and neonatology is essential for optimal maternal-fetal outcomes. Despite the predominance of clear cell RCC in pregnancy, this case highlights the need for awareness of rarer subtypes like papillary RCC. The absence of standardized management guidelines underscores the importance of case-by-case assessment. Conclusion: Timely diagnosis, individualized surgical planning, and coordinated multidisciplinary care are crucial in managing RCC during pregnancy, particularly for rare histological variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.